Crinetics Pharmaceuticals Statistics

Total Valuation

CRNX has a market cap or net worth of $5.20 billion. The enterprise value is $4.39 billion.

Market Cap	5.20B
Enterprise Value	4.39B

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

CRNX has 92.74 million shares outstanding. The number of shares has increased by 36.52% in one year.

Current Share Class	92.74M
Shares Outstanding	92.74M
Shares Change (YoY)	+36.52%
Shares Change (QoQ)	+1.37%
Owned by Insiders (%)	1.38%
Owned by Institutions (%)	93.59%
Float	91.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	2,858.61
PB Ratio	5.44
P/TBV Ratio	6.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4,224.90
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.38, with a Debt / Equity ratio of 0.06.

Current Ratio	16.38
Quick Ratio	16.24
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -40.26% and return on invested capital (ROIC) is -25.81%.

Return on Equity (ROE)	-40.26%
Return on Assets (ROA)	-24.29%
Return on Capital (ROIC)	-25.81%
Revenue Per Employee	$3,583
Profits Per Employee	-$958,310
Employee Count	290
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +86.96% in the last 52 weeks. The beta is 0.62, so CRNX's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	+86.96%
50-Day Moving Average	55.20
200-Day Moving Average	48.82
Relative Strength Index (RSI)	47.67
Average Volume (20 Days)	623,251

Short Selling Information

The latest short interest is 6.94 million, so 7.49% of the outstanding shares have been sold short.

Short Interest	6.94M
Short Previous Month	6.59M
Short % of Shares Out	7.49%
Short % of Float	7.59%
Short Ratio (days to cover)	8.47

Income Statement

In the last 12 months, CRNX had revenue of $1.04 million and -$277.91 million in losses. Loss per share was -$3.72.

Revenue	1.04M
Gross Profit	-49.60M
Operating Income	-306.77M
Pretax Income	-258.54M
Net Income	-277.91M
EBITDA	-304.51M
EBIT	-306.77M
Loss Per Share	-$3.72

Full Income Statement

Balance Sheet

The company has $862.67 million in cash and $52.54 million in debt, giving a net cash position of $810.13 million or $8.74 per share.

Cash & Cash Equivalents	862.67M
Total Debt	52.54M
Net Cash	810.13M
Net Cash Per Share	$8.74
Equity (Book Value)	832.98M
Book Value Per Share	10.30
Working Capital	824.03M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$199.81 million and capital expenditures -$3.75 million, giving a free cash flow of -$203.56 million.

Operating Cash Flow	-199.81M
Capital Expenditures	-3.75M
Free Cash Flow	-203.56M
FCF Per Share	-$2.20

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-29,525.22%
Pretax Margin	-26,747.83%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-13,360.94%

Dividends & Yields

CRNX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.52%
Shareholder Yield	-36.52%
Earnings Yield	-5.34%
FCF Yield	-3.91%

Analyst Forecast

The average price target for CRNX is $73.70, which is 31.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$73.70
Price Target Difference	31.44%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	152.58%
EPS Growth Forecast (5Y)	-54.58%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CRNX has an Altman Z-Score of 16.74 and a Piotroski F-Score of 2.

Altman Z-Score	16.74
Piotroski F-Score	2